PL3544630T3 - Kompozycja odżywcza ze skrobią oporną użyteczna w leczeniu chorób nowotworowych - Google Patents
Kompozycja odżywcza ze skrobią oporną użyteczna w leczeniu chorób nowotworowychInfo
- Publication number
- PL3544630T3 PL3544630T3 PL17808402T PL17808402T PL3544630T3 PL 3544630 T3 PL3544630 T3 PL 3544630T3 PL 17808402 T PL17808402 T PL 17808402T PL 17808402 T PL17808402 T PL 17808402T PL 3544630 T3 PL3544630 T3 PL 3544630T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- nutritional composition
- resistant starch
- neoplastic diseases
- starch useful
- Prior art date
Links
- 229920000294 Resistant starch Polymers 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001613 neoplastic effect Effects 0.000 title 1
- 235000016709 nutrition Nutrition 0.000 title 1
- 235000021254 resistant starch Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
- A23L29/219—Chemically modified starch; Reaction or complexation products of starch with other chemicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pediatric Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Marine Sciences & Fisheries (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16200981.5A EP3326650A1 (en) | 2016-11-28 | 2016-11-28 | Nutritional composition with resistant starch useful in the treatment of neoplastic diseases |
EP17808402.6A EP3544630B1 (en) | 2016-11-28 | 2017-11-27 | Nutritional composition with resistant starch useful in the treatment of neoplastic diseases |
PCT/EP2017/080468 WO2018096131A1 (en) | 2016-11-28 | 2017-11-27 | Nutritional composition with resistant starch useful in the treatment of neoplastic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3544630T3 true PL3544630T3 (pl) | 2021-10-25 |
Family
ID=57485305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL17808402T PL3544630T3 (pl) | 2016-11-28 | 2017-11-27 | Kompozycja odżywcza ze skrobią oporną użyteczna w leczeniu chorób nowotworowych |
Country Status (12)
Country | Link |
---|---|
US (1) | US11382928B2 (pl) |
EP (2) | EP3326650A1 (pl) |
AU (1) | AU2017364260A1 (pl) |
CA (1) | CA3045073C (pl) |
DK (1) | DK3544630T3 (pl) |
ES (1) | ES2870917T3 (pl) |
HR (1) | HRP20210630T1 (pl) |
HU (1) | HUE054506T2 (pl) |
LT (1) | LT3544630T (pl) |
PL (1) | PL3544630T3 (pl) |
PT (1) | PT3544630T (pl) |
WO (1) | WO2018096131A1 (pl) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN880996A0 (en) * | 1996-03-20 | 1996-04-18 | Arnott's Biscuits Limited | Selection and/or enhancement of resident microorganisms in the gastrointestinal tract |
US20070269580A1 (en) * | 2006-05-19 | 2007-11-22 | Charles Werstak | Processes for producing food compositions including legume products and products produced therefrom |
WO2012113415A1 (en) * | 2011-02-24 | 2012-08-30 | N.V. Nutricia | Ketogenic diet composition for the treatment of chemo therapy and/or radiation therapy patients |
AU2015319791A1 (en) * | 2014-09-19 | 2017-02-23 | Nestec Sa | Treatment of cancer with alpha-amylase inhibitor in companion animals |
-
2016
- 2016-11-28 EP EP16200981.5A patent/EP3326650A1/en not_active Withdrawn
-
2017
- 2017-11-27 LT LTEP17808402.6T patent/LT3544630T/lt unknown
- 2017-11-27 HU HUE17808402A patent/HUE054506T2/hu unknown
- 2017-11-27 ES ES17808402T patent/ES2870917T3/es active Active
- 2017-11-27 AU AU2017364260A patent/AU2017364260A1/en not_active Abandoned
- 2017-11-27 EP EP17808402.6A patent/EP3544630B1/en active Active
- 2017-11-27 US US16/463,568 patent/US11382928B2/en active Active
- 2017-11-27 PT PT178084026T patent/PT3544630T/pt unknown
- 2017-11-27 CA CA3045073A patent/CA3045073C/en active Active
- 2017-11-27 WO PCT/EP2017/080468 patent/WO2018096131A1/en active Application Filing
- 2017-11-27 PL PL17808402T patent/PL3544630T3/pl unknown
- 2017-11-27 DK DK17808402.6T patent/DK3544630T3/da active
-
2021
- 2021-04-21 HR HRP20210630TT patent/HRP20210630T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
US20190343866A1 (en) | 2019-11-14 |
PT3544630T (pt) | 2021-04-26 |
EP3544630A1 (en) | 2019-10-02 |
EP3326650A1 (en) | 2018-05-30 |
US11382928B2 (en) | 2022-07-12 |
CA3045073A1 (en) | 2018-05-31 |
DK3544630T3 (da) | 2021-04-26 |
EP3544630B1 (en) | 2021-03-24 |
CA3045073C (en) | 2024-05-21 |
WO2018096131A1 (en) | 2018-05-31 |
AU2017364260A1 (en) | 2019-06-20 |
HUE054506T2 (hu) | 2021-09-28 |
HRP20210630T1 (hr) | 2021-06-25 |
ES2870917T3 (es) | 2021-10-28 |
AU2017364260A2 (en) | 2019-06-27 |
LT3544630T (lt) | 2021-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2560282B (en) | Illumination content production and use | |
HK1256283A1 (zh) | 治療癌症有用的二氫咪唑並吡嗪酮衍生物 | |
IL254142B (en) | Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent | |
HK1245658A1 (zh) | 可用於治療ibd患者的營養組合物 | |
ZA201804950B (en) | Indolinones compounds and their use in the treatment of fibrotic diseases | |
LT3405213T (lt) | Bakteriniai šešėliai, skirti panaudoti vėžio gydyme | |
HK1209359A1 (en) | Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases | |
GB201700692D0 (en) | Novel compounds and their use in the treatment of schistosomiasis | |
IL269121A (en) | Usl-311 for use in the treatment of cancer | |
RS65009B1 (sr) | Sastav za upotrebu u lečenju crevnih promena | |
ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
HK1209357A1 (en) | Use of dialister invisus in the treatment or prevention of rheumatoid arthritis or related diseases | |
GB201514018D0 (en) | Novel tricyclic compounds and their use in the treatment of cancer | |
IL270788A (en) | Sulfonylurea compounds in the treatment of disease associated with uv-induced damage | |
PL3544630T3 (pl) | Kompozycja odżywcza ze skrobią oporną użyteczna w leczeniu chorób nowotworowych | |
HK1209369A1 (en) | Use of alistipes shahii in the treatment or prevention of rheumatoid arthritis or related diseases | |
SG10201500884WA (en) | Manufacture Of Vascular Smooth Muscle Cells And The Use | |
GB201616087D0 (en) | Algae comprising therapeutic and/or nutritional agents | |
AU2016143V (en) | Suncap5 Liriope muscari | |
GB201511772D0 (en) | Improvements in the treatment of ash | |
PL3161209T3 (pl) | Zastosowanie mąki z pszenicy w procesie papierniczym | |
AU358216S (en) | A flexible gemstone setting |